Latest Insider Transactions at Stoke Therapeutics, Inc. (STOK)
This section provides a real-time view of insider transactions for Stoke Therapeutics, Inc. (STOK). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Stoke Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Stoke Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 08
2025
|
Edward M. Md Kaye |
SELL
Open market or private sale
|
Direct |
13,430
-7.61%
|
$429,760
$32.35 P/Share
|
|
Dec 08
2025
|
Jonathan Allan GENERAL COUNSEL & CORP SEC |
SELL
Open market or private sale
|
Direct |
3,978
-13.34%
|
$127,296
$32.11 P/Share
|
|
Dec 05
2025
|
Edward M. Md Kaye |
SELL
Open market or private sale
|
Direct |
8,548
-4.11%
|
$264,988
$31.44 P/Share
|
|
Dec 05
2025
|
Barry Ticho CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,662
-8.13%
|
$113,522
$31.34 P/Share
|
|
Dec 05
2025
|
Jonathan Allan GENERAL COUNSEL & CORP SEC |
SELL
Open market or private sale
|
Direct |
8,785
-13.35%
|
$272,335
$31.39 P/Share
|
|
Dec 04
2025
|
Edward M. Md Kaye |
SELL
Open market or private sale
|
Direct |
6,453
-4.22%
|
$200,043
$31.04 P/Share
|
|
Dec 04
2025
|
Barry Ticho CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,696
-3.41%
|
$52,576
$31.04 P/Share
|
|
Dec 04
2025
|
Jonathan Allan GENERAL COUNSEL & CORP SEC |
SELL
Open market or private sale
|
Direct |
1,018
-2.0%
|
$31,558
$31.04 P/Share
|
|
Dec 03
2025
|
Edward M. Md Kaye |
BUY
Exercise of conversion of derivative security
|
Direct |
26,250
+25.29%
|
-
|
|
Dec 03
2025
|
Barry Ticho CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+28.44%
|
-
|
|
Dec 03
2025
|
Jonathan Allan GENERAL COUNSEL & CORP SEC |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+18.98%
|
-
|
|
Dec 03
2025
|
Jonathan Allan GENERAL COUNSEL & CORP SEC |
SELL
Open market or private sale
|
Direct |
2,292
-5.37%
|
$68,760
$30.6 P/Share
|
|
Dec 03
2025
|
Edward M. Md Kaye |
SELL
Open market or private sale
|
Direct |
1,070
-1.03%
|
$32,100
$30.6 P/Share
|
|
Dec 03
2025
|
Barry Ticho CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,014
-6.04%
|
$60,420
$30.6 P/Share
|
|
Dec 02
2025
|
Jonathan Allan GENERAL COUNSEL & CORP SEC |
SELL
Open market or private sale
|
Direct |
2,284
-4.83%
|
$66,236
$29.85 P/Share
|
|
Dec 02
2025
|
Edward M. Md Kaye |
SELL
Open market or private sale
|
Direct |
1,066
-1.0%
|
$30,914
$29.85 P/Share
|
|
Dec 02
2025
|
Barry Ticho CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,006
-5.37%
|
$58,174
$29.85 P/Share
|
|
Dec 01
2025
|
Jonathan Allan GENERAL COUNSEL & CORP SEC |
BUY
Exercise of conversion of derivative security
|
Direct |
12,357
+33.81%
|
-
|
|
Dec 01
2025
|
Barry Ticho CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
11,981
+38.45%
|
-
|
|
Nov 24
2025
|
Adrian R. Krainer |
SELL
Open market or private sale
|
Direct |
40,472
-11.11%
|
$1,173,688
$29.72 P/Share
|
|
Nov 14
2025
|
Adrian R. Krainer |
SELL
Open market or private sale
|
Direct |
40,472
-5.13%
|
$1,052,272
$26.98 P/Share
|
|
Nov 03
2025
|
Barry Ticho CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
5,931
-13.32%
|
$160,137
$27.03 P/Share
|
|
Oct 08
2025
|
Edward M. Md Kaye |
SELL
Open market or private sale
|
Direct |
25,000
-33.73%
|
$750,000
$30.0 P/Share
|
|
Oct 08
2025
|
Edward M. Md Kaye |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+25.22%
|
$0
$0.6 P/Share
|
|
Oct 03
2025
|
Jonathan Allan GENERAL COUNSEL & CORP SEC |
SELL
Open market or private sale
|
Direct |
10,000
-45.81%
|
$250,000
$25.07 P/Share
|
|
Oct 03
2025
|
Jonathan Allan GENERAL COUNSEL & CORP SEC |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+31.42%
|
$90,000
$9.15 P/Share
|
|
Oct 03
2025
|
Edward M. Md Kaye |
SELL
Open market or private sale
|
Direct |
42,461
-46.36%
|
$1,061,525
$25.09 P/Share
|
|
Oct 01
2025
|
Barry Ticho CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
5,343
-28.93%
|
$122,889
$23.64 P/Share
|
|
Sep 30
2025
|
Arthur A Levin |
BUY
Exercise of conversion of derivative security
|
Direct |
1,211
+25.01%
|
-
|
|
Sep 03
2025
|
Jonathan Allan GENERAL COUNSEL & CORP SEC |
SELL
Open market or private sale
|
Direct |
6,345
-34.91%
|
$126,900
$20.07 P/Share
|
|
Sep 03
2025
|
Edward M. Md Kaye |
SELL
Open market or private sale
|
Direct |
45,996
-33.43%
|
$919,920
$20.13 P/Share
|
|
Sep 02
2025
|
Jonathan Allan GENERAL COUNSEL & CORP SEC |
SELL
Open market or private sale
|
Direct |
14,922
-45.08%
|
$298,440
$20.14 P/Share
|
|
Sep 02
2025
|
Jonathan Allan GENERAL COUNSEL & CORP SEC |
BUY
Exercise of conversion of derivative security
|
Direct |
9,150
+21.66%
|
$64,050
$7.07 P/Share
|
|
Sep 02
2025
|
Edward M. Md Kaye |
SELL
Open market or private sale
|
Direct |
14,860
-9.75%
|
$297,200
$20.14 P/Share
|
|
Sep 02
2025
|
Barry Ticho CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
5,501
-22.95%
|
$104,519
$19.87 P/Share
|
|
Aug 29
2025
|
Jonathan Allan GENERAL COUNSEL & CORP SEC |
SELL
Open market or private sale
|
Direct |
850
-3.43%
|
$17,000
$20.0 P/Share
|
|
Aug 29
2025
|
Jonathan Allan GENERAL COUNSEL & CORP SEC |
BUY
Exercise of conversion of derivative security
|
Direct |
850
+3.31%
|
$5,950
$7.07 P/Share
|
|
Aug 29
2025
|
Edward M. Md Kaye |
SELL
Open market or private sale
|
Direct |
1,029
-0.67%
|
$20,580
$20.0 P/Share
|
|
Aug 18
2025
|
Jonathan Allan GENERAL COUNSEL & CORP SEC |
SELL
Open market or private sale
|
Direct |
1,683
-6.57%
|
$30,294
$18.24 P/Share
|
|
Aug 18
2025
|
Edward M. Md Kaye |
SELL
Open market or private sale
|
Direct |
12,126
-7.32%
|
$218,268
$18.24 P/Share
|
|
Aug 18
2025
|
Barry Ticho CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,805
-10.48%
|
$50,490
$18.24 P/Share
|
|
Aug 14
2025
|
Barry Ticho CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+27.19%
|
-
|
|
Aug 14
2025
|
Edward M. Md Kaye |
BUY
Exercise of conversion of derivative security
|
Direct |
26,250
+13.68%
|
-
|
|
Aug 14
2025
|
Jonathan Allan GENERAL COUNSEL & CORP SEC |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+18.97%
|
-
|
|
Aug 13
2025
|
Jonathan Allan GENERAL COUNSEL & CORP SEC |
SELL
Open market or private sale
|
Direct |
13,712
-41.12%
|
$205,680
$15.0 P/Share
|
|
Aug 01
2025
|
Barry Ticho CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
4,504
-21.17%
|
$54,048
$12.82 P/Share
|
|
Jul 01
2025
|
Barry Ticho CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
4,503
-17.47%
|
$49,533
$11.63 P/Share
|
|
Jun 30
2025
|
Arthur A Levin |
BUY
Exercise of conversion of derivative security
|
Direct |
1,210
+33.33%
|
-
|
|
Jun 04
2025
|
Skorpios Trust > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
3,000,000
-43.44%
|
$30,000,000
$10.2 P/Share
|
|
Jun 03
2025
|
Barry Ticho CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
6,471
-20.06%
|
$64,710
$10.03 P/Share
|